Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrauterine injection of hCG-treated PBMCs for recurrent implantation failure
IRCT20250701066326N1Phase 2Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Sep 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of human chorionic gonadotropin in Recurrent Implantation Failure (RIF), sponsored by Mazandaran University of Medical Sciences. Started Sep 2025; status: completed.
02
Drugs
human chorionic gonadotropin
03
Conditions
Recurrent Implantation Failure (RIF)
Beyond the preview
Go deeper on IRCT20250701066326N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250701066326N1.